Approval · Notice of Compliance 23283 · 2018
OTOMAX: Notice of Compliance 23283
Issued September 26, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23283
- Date
- September 26, 2018
- Company
- Intervet Canada CorpKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a drug product manufacturing site, labelling updates
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OTOMAX | 00817112 | Marketed |
Medicinal ingredients
- CLOTRIMAZOLE 10 MG per G
- GENTAMICIN SULFATE 3 MG per G
- BETAMETHASONE VALERATE 1 MG per G